Swiss pharma giant Roche presents positive data on eye disease drug
This content was published on
Basel-based pharmaceutical company Roche has reported positive Phase III results for its eye disease treatment, vamikibart.
Explainer: Watches win, pharma waits as Swiss-India trade deal turns one
This content was published on
In October 2025, Switzerland, as a member state of EFTA, entered into what was billed as a historic free trade deal with India.
This content was published on
Swiss pharmaceutical giant Roche outlined its ambitious future plans, which include greater use of artificial intelligence to speed up research and development discovery, at its pharma investor day on Monday.
Novartis shares plummet after another clinical trial setback
This content was published on
Shares in the market heavyweight plummeted by over 10% at one point during early trading on Tuesday following the failure of a trial into a drug for a muscle disorder.
